BICLUSTER_ID : UPREG-6
PATHOGENS /2/ : listeria monocytogenes,mycobacterium tuberculosis
TARGETS /63/ : GSTO1, PPARD, ANXA2, ALDOA, GCH1, UGCG, SAT1, CXCL10, CFB, P4HA1, NFKB1, FCGR2B, GPRC5A, HSPA5, PPIF, JAK2, GLRX, ABCC1, LSS, CCL8, IL1B, CASP1, IL1R1, GCLM, CCL20, PDE4B, JUN, ACSL1, TNFRSF1B, GLA, CASP7, IL1R2, PSMD1, AMPD3, ADCY7, HTATIP2, PIM1, MAOA, CD59, TXNRD1, S100A11, PSMB2, STAT1, CBR1, NRP1, HLA-DQA1, IL12B, MMP9, HMOX1, WARS, HSPA1B, CYP51A1, CALM1, IFNB1, IL6, PTGS2, PLOD2, CLK1, P4HA2, IL8, TNF, PLAUR, HSPA1A
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPIL6ST, PFKFB3, BTG3, LYN, NMI, TLR4, PMAIP1, TXN, IFI44, CREM, CFLAR, NFKB1, IFIT1, B4GALT5, SP100, TNFSF10, GADD45G, SRC, PTP4A1, BAG1, IFITM3, LCP2, RGS1, CD53, IL1B, CASP1, IL1R1, UPP1, AHR, PDE4B, GBP1, STAT4, ACSL1, ISGF3G, SOS1, TNFRSF1B, PSCDBP, NR4A2, PIM1, CASP10, FOSL2, TXNRD1, CCL4, IER3, STAT1, KLF6, DUSP5, VIM, WARS, TRIM21, ATP1B1, CYP51A1, USP15, IL6, IL8, MX1, TNF, PLAUR
NETPATH TNF ALPHA PATHWAY UPEMP1, IL7R, MBP, IFIT5, HBEGF, PMAIP1, TXN, NFKBIA, GCH1, INHBA, PSMA3, UGCG, CXCL10, CFLAR, C2, APOL3, CXCL1, JUNB, TNFSF10, CSTB, TNFAIP3, IL15RA, ATP6V1F, BID, GALNAC4S-6ST, PSMA5, ISGF3G, TMSB10, CASP7, CXCL3, IER3, S100A11, DFNA5, PPP1R15A, VRK2, TRIM21, MITF, IFNB1, IL6, PTGS2, ZFP36, DUSP1, MX1, G0S2, BTG3, EGR1, FLRT2, CXCL2, RIPK2, SOD2, CASP4, EMP3, NFKB1, IFITM1, RCBTB2, TNIP1, PML, GBP2, BCL2A1, IFITM3, WTAP, IL1B, CHST2, CCL18, NR4A3, STAT4, NCK1, ARMCX1, TNFRSF1B, GK, PIR, CD59, IFIT2, UNC13B, CBR3, WARS, ADAM17, CCL13, PRDX1, IFI27, IL8, ELOVL5, PLAUR
GERY CEBP TARGETSGADD45B, EREG, ACSL1, DDIT3, BAG3, HBEGF, GLA, CD47, RGS16, HTATIP2, GCH1, PIM1, SAT1, BTG2, RGS2, NRP1, HMOX1, GLRX, CXCL1, HSPA1B, LSS, JUNB, GADD45G, RRAD, TNFAIP6, ATF3, IFRD1, DUSP1, PLAUR
NETPATH IL 1 PATHWAY UPNR4A3, CCL20, HBEGF, FOSL1, NFKBIA, AMPD3, PSMA3, INHBA, SLC25A28, CXCL2, TXNRD1, SOD2, CCL4, CFB, NFKB1, CXCL1, WARS, CCL8, CCL13, TNFAIP6, IL6, PTGS2, IL1B, ZFP36, IL8
NCI IL23PATHWAYNFKB1, STAT1, IL12B, CXCL1, JAK2, STAT4, IL18R1, NFKBIA, IL6, IL19, IL1B, STAT3, TNF
NETPATH IL 5 PATHWAY UPRHOH, GCLM, GSTO1, PLSCR1, PDE4B, TLR1, HIF1A, GK, EGR1, FOSL2, NFE2L2, IER3, MYD88, CASP4, NFKB1, DUSP5, PPIF, CLEC2B, HSPA6, MAPK6, TBK1, IL1B, IL8, UPP1
NCI LYSOPHOSPHOLIPID PATHWAYNFKB1, TRIP6, MMP9, JUN, EDG7, HBEGF, LYN, GNA13, TIAM1, SRC, NFKBIA, ADCY8, IL6, ADCY7, GNA15, IL8
NETPATH IL 6 PATHWAY UPGADD45B, PPARD, HBEGF, MAP3K8, NMI, RHOBTB3, PIM1, STAT1, ABCC1, CXCL1, MMP9, CEBPB, JUNB, MAFF, ZFP36, PRDM1, TNF, MX1
NETPATH TNF ALPHA PATHWAY DOWNIFIT5, NFKBIA, EGR1, EXT1, CXCL2, SIPA1L1, NFKB1, CXCL1, JUNB, CLEC2B, TNFSF10, HSPA6, MAPK6, TIPARP, MAFF, GEM, TNFAIP3, CCL20, ATP6V1C1, HIF1A, CXCL3, SDC4, FOSL2, IER3, CBR1, INSIG1, KLF6, PPP1R15A, DUSP2, IL6, CLK1, PTGS2, ZFP36
NETPATH IL 4 PATHWAY UPFGL2, AHR, ELL2, SOS1, ARID5B, TLR4, IL1RN, EXT1, INHBA, MAOA, TFEC, RIPK2, CREM, PTX3, NFKB1, MXD1, HLA-DQA1, CEBPB, MAF, IL6, IL10RA, EBI2, RSAD2, CTSC, LOC51334, CTSL, SLC11A2, UPP1
NCI IL1PATHWAYIL1R2, SQSTM1, NFKB1, IL1RN, IL1B, CASP1, MAP3K7IP2, MYD88
NETPATH IL 3 PATHWAY UPANXA2, SPP1, CCR1, NFIL3, IL1B, PIM1, IL8, CCL4
NCI TNFPATHWAYNFKB1, STAT1, CASP8, CYLD, TNFRSF1B, ADAM17, SQSTM1, NSMAF, TXN, TNFAIP3, TNF
NETPATH IL 4 PATHWAY DOWNGADD45B, CCL20, IL7R, NFKBIA, IFI16, ITPKB, CXCL2, STAT1, UBE2L6, VIM, CLEC2B, TNFSF10, GBP2, PTGS2, NINJ1, BCL6, IL8, MX1
NETPATH T CELL RECEPTOR PATHWAY DOWNIFITM1, IL7R, CHST11, NFKBIA, RSN, CLK1, STOM, CASP1, BLZF1, IRF7, HIST1H2AC, HSPA1A, TNF
MENSE HYPOXIA UPPFKFB3, HK2, ELL2, ADFP, KLHL24, BNIP3L, SOD2, PTDSR, P4HA1, C6ORF166, INSIG1, PBEF1 /// LOC646309, PPP1R15A, CEBPB, TIPARP, MAFF, ATF3, PLOD2, P4HA2, ADM, BNIP3
NCI BCR 5PATHWAYNFKB1, FCGR2B, LYN, SOS1, BCL2A1, CALM1, SH3BP5, NFKBIA, PPP3CC
NETPATH EGFR1 PATHWAY UPSNAI1, NR4A3, EREG, HBEGF, PHLDA2, EGR1, ITGB5, IER3, GPRC5A, VIM, TNFAIP3, PTGS2, CASP5, WDR26, PLAUR, DUSP1
NETPATH WNT PATHWAY UPPSMA6, GPNMB, HSPA5, WNT5A, BTG3, MAPK6, IFI30, IL8, HES1, CREM, DUSP1, PLAUR
NCI HIF1 TFPATHWAYPFKFB3, HK2, HMOX1, NCOA1, TFRC, ADFP, HIF1A, ALDOA, ENO1, ADM, BNIP3
NCI VIF MEDIATED DEGRADATION OF APOBEC3GPSMD7, UBC, PSMA2, PSMA5, TCEB1, UBB, PSMD11, PSMA4, PSMC1, PSMD1, PSMB7, PSMA3, PSMB2, RBX1, PSMD14, PSMA1, PSMA6, PSMD12, PSMD8, PSMC2
GOLUB ALL VS AML DNSQSTM1, NFKBIA, PPIF, LYN, LGALS3 /// GALIG
NCI NFKAPPABCANONICALPATHWAYNFKB1, NFKBIA, TNFAIP3, RIPK2, CYLD
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION GRANULOCYTE DN
WEINMANN ADAPTATION TO HYPOXIA UP
BIOCARTA IL10 PATHWAY
REACTOME SIGNALING BY PDGF
NCI S1P S1P1 PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 6
CORUM ITGAV-ITGB5-PLAUR COMPLEX
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
MASSARWEH TAMOXIFEN RESISTANCE UP
BROWNE HCMV INFECTION 20HR UP
FAELT B CLL WITH VH REARRANGEMENTS UP
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
ASTON MAJOR DEPRESSIVE DISORDER DN
BIOCARTA RELA PATHWAY
RADAEVA RESPONSE TO IFNA1 UP
GAZDA DIAMOND BLACKFAN ANEMIA PROGENITOR UP
SESTO RESPONSE TO UV C0
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS YELLOW UP
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
NETPATH IL 7 PATHWAY UP
MUNSHI MULTIPLE MYELOMA UP
AMIT EGF RESPONSE 480 HELA
NAKAYAMA FRA2 TARGETS
NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21UBC, PSMA2, PSMA5, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMA3, PSMD14, PSMA1, PSMA6, CUL1, PSMD12, PSMD8, PSMC2
HEDVAT ELF4 TARGETS UP
REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
LENAOUR DENDRITIC CELL MATURATION DN
KUMAR TARGETS OF MLL AF9 FUSION
AGARWAL AKT PATHWAY TARGETS
DOUGLAS BMI1 TARGETS DN
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
SCHEIDEREIT IKK INTERACTING PROTEINS
AMIT EGF RESPONSE 240 MCF10A
AMIT SERUM RESPONSE 60 MCF10A
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
BROWNE HCMV INFECTION 16HR UP
NCI APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
VART KSHV INFECTION ANGIOGENIC MARKERS DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
REACTOME APOPTOSIS
MCLACHLAN DENTAL CARIES UP
CHOW RASSF1 TARGETS DN
GAJATE RESPONSE TO TRABECTEDIN UP
HELLER SILENCED BY METHYLATION UP
GOZGIT ESR1 TARGETS DN
WOOD EBV EBNA1 TARGETS DN
SMID BREAST CANCER LUMINAL B DN
SASSON RESPONSE TO GONADOTROPHINS DN
DORN ADENOVIRUS INFECTION 24HR DN
PUIFFE INVASION INHIBITED BY ASCITES DN
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
REACTOME GENERATION OF SECOND MESSENGER MOLECULES
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC DN
SPIRA SMOKERS LUNG CANCER UP
TIAN TNF SIGNALING VIA NFKB
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
KEGG APOPTOSIS
SUH COEXPRESSED WITH ID1 AND ID2 UP
NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEXUBC, PSMA2, PSMA5, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMA3, PSMD14, PSMA1, PSMA6, CUL1, PSMD12, CSNK1A1, PSMD8, PSMC2
ABRAHAM ALPC VS MULTIPLE MYELOMA UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
COLIN PILOCYTIC ASTROCYTOMA VS GLIOBLASTOMA DN
BROWNE HCMV INFECTION 12HR UP
SESTO RESPONSE TO UV C1
BIOCARTA BCR PATHWAY
BOYLAN MULTIPLE MYELOMA C DN
SIMBULAN UV RESPONSE NORMAL UP
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
KIM LRRC3B TARGETS
SEMBA FHIT TARGETS UP
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
REACTOME UNFOLDED PROTEIN RESPONSE
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
DIRMEIER LMP1 RESPONSE LATE UP
AMIT EGF RESPONSE 20 HELA
HOUSTIS ROS
BIOCARTA NTHI PATHWAY
MARZEC IL2 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
CHIBA RESPONSE TO TSA DN
ENK UV RESPONSE EPIDERMIS DN
LINDGREN BLADDER CANCER CLUSTER 2A DN
BOYLAN MULTIPLE MYELOMA C D DN
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
SABATES COLORECTAL ADENOMA SIZE DN
CORUM UBIQUITIN E3 LIGASE TRIM25 DDX58
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
NETPATH WNT PATHWAY DOWN
NCI P75NTR RECRUITS SIGNALLING COMPLEXES
SANA RESPONSE TO IFNG UP
KORKOLA EMBRYONAL CARCINOMA
SCHEIDEREIT IKK TARGETS
MARTINEZ RESPONSE TO TRABECTEDIN UP
NCI NF KB IS ACTIVATED AND SIGNALS SURVIVAL
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 UP
HOEBEKE LYMPHOID STEM CELL UP
DAZARD UV RESPONSE CLUSTER G24
MURAKAMI UV RESPONSE 6HR UP
MOSERLE IFNA RESPONSE
WANG METHYLATED IN BREAST CANCER
CORUM 26S PROTEASOME
HOLLMAN APOPTOSIS VIA CD40 DN
REACTOME SIGNALING BY WNT
RODWELL AGING KIDNEY UP
REACTOME TOLL RECEPTOR CASCADES
BREDEMEYER RAG SIGNALING VIA ATM NOT VIA NFKB UP
REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC
ONDER CDH1 TARGETS 1 DN
NCI SMAD2 3NUCLEARPATHWAY
VALK AML CLUSTER 5
MORI IMMATURE B LYMPHOCYTE UP
REACTOME ACTIVATED TLR4 SIGNALLING
ELVIDGE HYPOXIA BY DMOG UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25APSMA6, PSMA1, PSMD14, UBC, PSMD12, PSMA2, PSMA5, PSMD8, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
KIM WT1 TARGETS 8HR UP
KOBAYASHI RESPONSE TO ROMIDEPSIN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
ELVIDGE HIF1A TARGETS DN
LI CISPLATIN RESISTANCE DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
ZHU CMV 24 HR UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
OUELLET OVARIAN CANCER INVASIVE VS LMP UP
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
NETPATH IL 1 PATHWAY
MORI LARGE PRE BII LYMPHOCYTE DN
XU HGF TARGETS REPRESSED BY AKT1 UP
REACTOME TRANSLOCATION OF ZAP70 TO IMMUNOLOGICAL SYNAPSE
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
NCI IL6 7PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
KAAB FAILED HEART VENTRICLE DN
DAZARD UV RESPONSE CLUSTER G3
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
BIOCARTA PROTEASOME PATHWAY
DUTTA APOPTOSIS VIA NFKB
CORUM ITGAV-ITGB3-CD47-FCER2 COMPLEX
DER IFN GAMMA RESPONSE UP
NCI VPU MEDIATED DEGRADATION OF CD4PSMA6, PSMA1, PSMD14, UBC, PSMD12, PSMA2, PSMA5, PSMD8, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
KANG CISPLATIN RESISTANCE UP
BIOCARTA FREE PATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
NCI CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6
LU AGING BRAIN DN
NEWMAN ERCC6 TARGETS UP
NCI PRLSIGNALINGEVENTSPATHWAY
NCI CD8TCRPATHWAY
FOSTER INFLAMMATORY RESPONSE LPS DN
REACTOME P53 INDEPENDENT DNA DAMAGE RESPONSE
GAURNIER PSMD4 TARGETS
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
APPEL IMATINIB RESPONSE
LEE LIVER CANCER MYC E2F1 UP
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN
BASSO HAIRY CELL LEUKEMIA DN
GEISS RESPONSE TO DSRNA UP
SA B CELL RECEPTOR COMPLEXES
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
REACTOME SPHINGOLIPID METABOLISM
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
GENTILE UV HIGH DOSE DN
ZHOU INFLAMMATORY RESPONSE FIMA UP
REACTOME VIRAL DSRNA TLR3 TRIF COMPLEX ACTIVATES RIP1
GRUETZMANN PANCREATIC CANCER UP
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1PSMA6, PSMA1, PSMD14, UBC, PSMD12, PSMA2, PSMA5, PSMD8, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
OKUMURA INFLAMMATORY RESPONSE LPS
KEGG PROTEASOME
NATSUME RESPONSE TO INTERFERON BETA UP
KRIGE AMINO ACID DEPRIVATION
GAZDA DIAMOND BLACKFAN ANEMIA MYELOID UP
AMIT EGF RESPONSE 60 MCF10A
WAMUNYOKOLI OVARIAN CANCER LMP DN
NCI NICOTINATE METABOLISM
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
LEONARD HYPOXIA
CHEN LVAD SUPPORT OF FAILING HEART DN
NCI PDGFRAPATHWAY
DORN ADENOVIRUS INFECTION 32HR DN
JIANG HYPOXIA NORMAL
WU CELL MIGRATION
WALLACE PROSTATE CANCER RACE UP
CHANDRAN METASTASIS DN
NETPATH IL 7 PATHWAY DOWN
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE
BEIER GLIOMA STEM CELL DN
BROWNE HCMV INFECTION 2HR DN
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
AMUNDSON GENOTOXIC SIGNATURE
EHRLICH ICF SYNDROM DN
DORN ADENOVIRUS INFECTION 12HR DN
UROSEVIC RESPONSE TO IMIQUIMOD
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
REACTOME INNATE IMMUNITY SIGNALING
ENK UV RESPONSE KERATINOCYTE UP
XU RESPONSE TO TRETINOIN AND NSC682994 UP
GUTIERREZ MULTIPLE MYELOMA DN
LAIHO COLORECTAL CANCER SERRATED UP
REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
CORUM ITGB3-ITGAV-CD47 COMPLEX
CORUM ITGA2B-ITGB3-CD47-SRC COMPLEX
NCI DOWNSTREAM TCR SIGNALING
RASHI RESPONSE TO IONIZING RADIATION 1
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY UP
KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION
BILD HRAS ONCOGENIC SIGNATURE
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR DN
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
DER IFN ALPHA RESPONSE UP
BIOCARTA RNA PATHWAY
GRABARCZYK BCL11B TARGETS UP
ZUCCHI METASTASIS UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
DAZARD UV RESPONSE CLUSTER G2
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION DN
AMUNDSON RESPONSE TO ARSENITE
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
REACTOME DOWNSTREAM TCR SIGNALING
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
THUM SYSTOLIC HEART FAILURE UP
NCI IL27PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
MANALO HYPOXIA UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KEGG HEMATOPOIETIC CELL LINEAGE
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE
NCI PI3KCIPATHWAY
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
NETPATH ANDROGEN RECEPTOR PATHWAY UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
BAELDE DIABETIC NEPHROPATHY DN
NCI IL12 STAT4PATHWAY
CHIANG LIVER CANCER SUBCLASS INTERFERON UP
NETPATH T CELL RECEPTOR PATHWAY UP
HELLER HDAC TARGETS DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATIONPSMA6, PSMA1, PSMD14, UBC, PSMD12, PSMA2, PSMA5, PSMD8, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
KEGG ANTIGEN PROCESSING AND PRESENTATION
LU IL4 SIGNALING
REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
BIOCARTA IL6 PATHWAY
VANHARANTA UTERINE FIBROID DN
LINDGREN BLADDER CANCER CLUSTER 2B
CHUANG OXIDATIVE STRESS RESPONSE UP
KEGG GRAFT VERSUS HOST DISEASE
KEGG LYSOSOME
NCI HOST INTERACTIONS OF HIV FACTORSPSMA6, PSMA1, PSMD14, UBC, PSMD12, PSMA2, PSMA5, PSMD8, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
BRUECKNER TARGETS OF MIRLET7A3 DN
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
LINDSTEDT DENDRITIC CELL MATURATION D
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
SESTO RESPONSE TO UV C5
AMIT EGF RESPONSE 40 HELA
MILI PSEUDOPODIA CHEMOTAXIS DN
KIM WT1 TARGETS 12HR DN
BROWNE HCMV INFECTION 10HR UP
KEGG SPHINGOLIPID METABOLISM
MITSIADES RESPONSE TO APLIDIN UP
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
MORI MATURE B LYMPHOCYTE UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
CONRAD GERMLINE STEM CELL
MARTORIATI MDM4 TARGETS FETAL LIVER UP
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
CORUM PA28GAMMA-20S PROTEASOME
MARKEY RB1 ACUTE LOF UP
REN ALVEOLAR RHABDOMYOSARCOMA DN
XU AKT1 TARGETS 6HR
COULOUARN TEMPORAL TGFB1 SIGNATURE DN
DORSEY GAB2 TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
POOLA INVASIVE BREAST CANCER UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
LIU VAV3 PROSTATE CARCINOGENESIS UP
SHIPP DLBCL VS FOLLICULAR LYMPHOMA UP
BROWNE HCMV INFECTION 6HR UP
DAUER STAT3 TARGETS DN
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
NCI TGFBRPATHWAY
BOYAULT LIVER CANCER SUBCLASS G1 DN
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
WEST ADRENOCORTICAL CARCINOMA VS ADENOMA DN
DIRMEIER LMP1 RESPONSE LATE DN
HOSHIDA LIVER CANCER SUBCLASS S1
JAATINEN HEMATOPOIETIC STEM CELL DN
CORUM ABIN2-NFKB1-MAP3K8 COMPLEX
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
NCI REDUCTION OF CYTOSOLIC RIBONUCLEOSIDE 5 DIPHOSPHATES TO DEOXYRIBONUCLEOSIDE 5 DIPHOSPHATES BY RIBONUCLEOTIDE REDUCTASE AND THIOREDOXIN
WANG SMARCE1 TARGETS DN
BOWIE RESPONSE TO TAMOXIFEN
ZHOU INFLAMMATORY RESPONSE LPS UP
TOOKER GEMCITABINE RESISTANCE DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SUNG METASTASIS STROMA UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
NING CHRONIC OBSTRUCTIVE PULMONARY DISEASE DN
VANTVEER BREAST CANCER ESR1 DN
FINAK BREAST CANCER SDPP SIGNATURE
STEARMAN LUNG CANCER EARLY VS LATE DN
CORUM PA700-20S-PA28 COMPLEXPSMA6, PSMA1, PSMD14, PSMD12, PSMA2, PSMA5, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
REACTOME TOLL LIKE RECEPTOR 4 CASCADE
BROCKE APOPTOSIS REVERSED BY IL6
GENTILE UV RESPONSE CLUSTER D6
NCI P53DOWNSTREAMPATHWAY
NCI IL12 2PATHWAY
TAKAO RESPONSE TO UVB RADIATION DN
HUMMEL BURKITTS LYMPHOMA DN
GENTILE UV LOW DOSE UP
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
LEE EARLY T LYMPHOCYTE DN
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL DN
FLECHNER BIOPSY KIDNEY TRANSPLANT OK VS DONOR UP
KOYAMA SEMA3B TARGETS DN
PAPASPYRIDONOS UNSTABLE ATEROSCLEROTIC PLAQUE UP
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
NCI ERBB1 DOWNSTREAM PATHWAY
WANG ESOPHAGUS CANCER VS NORMAL DN
CROONQUIST STROMAL STIMULATION UP
SA MMP CYTOKINE CONNECTION
DORN ADENOVIRUS INFECTION 48HR UP
ZHANG RESPONSE TO CANTHARIDIN UP
BLUM RESPONSE TO SALIRASIB UP
KINSEY TARGETS OF EWSR1 FLII FUSION DN
LI WILMS TUMOR VS FETAL KIDNEY 1 UP
NCI APC C CDC20 MEDIATED DEGRADATION OF SECURIN
KHETCHOUMIAN TRIM24 TARGETS UP
HORIUCHI WTAP TARGETS UP
ONKEN UVEAL MELANOMA UP
CORUM PA28-20S PROTEASOMEPSMA1, PSMA6, PSMA4, PSMB7, PSMA3, PSMA5
DORN ADENOVIRUS INFECTION 12HR UP
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
DORN ADENOVIRUS INFECTION 32HR UP
RIGGI EWING SARCOMA PROGENITOR UP
BIOCARTA TH1TH2 PATHWAY
TSAI DNAJB4 TARGETS UP
DER IFN BETA RESPONSE UP
MORI PRE BI LYMPHOCYTE DN
NCI REGULATED PROTEOLYSIS OF P75NTR
GILDEA METASTASIS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
BASSO CD40 SIGNALING UP
TIAN TNF SIGNALING NOT VIA NFKB
BIOCARTA FCER1 PATHWAY
IVANOVA HEMATOPOIESIS LATE PROGENITOR
NAGASHIMA NRG1 SIGNALING UP
ZERBINI RESPONSE TO SULINDAC UP
CORUM UBIQUITIN E3 LIGASE NFKBIA BTRC CUL1 SKP1A
WANG ESOPHAGUS CANCER VS NORMAL UP
CORUM SDCBP-CTNNB1-CTNNA1-CDH1 COMPLEX
NETPATH B CELL RECEPTOR PATHWAY UP
SASSON RESPONSE TO FORSKOLIN DN
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG VIRAL MYOCARDITIS
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
KEGG LEISHMANIA INFECTION
REACTOME COSTIMULATION BY THE CD28 FAMILY
ELVIDGE HIF1A AND HIF2A TARGETS DN
SMITH TERT TARGETS UP
CHEN HOXA5 TARGETS 9HR UP
WANG RECURRENT LIVER CANCER DN
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
BIOCARTA DEATH PATHWAY
SEKI INFLAMMATORY RESPONSE LPS UP
ALCALAY AML BY NPM1 LOCALIZATION UP
REACTOME DNA STRAND ELONGATION
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
NCI UBIQUITIN DEPENDENT DEGRADATION OF CYCLIN D1PSMA6, PSMA1, UBC, PSMA5, PSMD11, PSMC1, PSMA4, PSMB7, PSMC2, PSMA3
FOSTER INFLAMMATORY RESPONSE LPS UP
RICKMAN HEAD AND NECK CANCER C
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN
BIOCARTA ASBCELL PATHWAY
CORUM 20S PROTEASOME
SENESE HDAC1 TARGETS UP
WANG CLIM2 TARGETS DN
KIM WT1 TARGETS UP
REACTOME P75NTR SIGNALS VIA NFKB
KEGG CYTOSOLIC DNA SENSING PATHWAY
STREICHER LSM1 TARGETS UP
CROONQUIST NRAS SIGNALING UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
CAVARD LIVER CANCER MALIGNANT VS BENIGN
AMIT EGF RESPONSE 120 MCF10A
MAHADEVAN IMATINIB RESISTANCE UP
BIOCARTA HIF PATHWAY
RUTELLA RESPONSE TO HGF UP
TOOKER RESPONSE TO BEXAROTENE UP
PRAMOONJAGO SOX4 TARGETS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
REACTOME PD1 SIGNALING
CORUM ITGAV-ITGB5-ADAM9 COMPLEX
NETPATH IL 5 PATHWAY
BIOCARTA PML PATHWAY
LENAOUR DENDRITIC CELL MATURATION UP
NCI GAB1 SIGNALOSOME
HAHTOLA MYCOSIS FUNGOIDES UP
BOYAULT LIVER CANCER SUBCLASS G5 DN
SWEET LUNG CANCER KRAS UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION A
BASAKI YBX1 TARGETS DN
HOFMANN CELL LYMPHOMA DN
ELVIDGE HYPOXIA UP
PROVENZANI METASTASIS DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 8
WATANABE ULCERATIVE COLITIS WITH CANCER DN
SESTO RESPONSE TO UV C2
TIEN INTESTINE PROBIOTICS 24HR DN
NUYTTEN NIPP1 TARGETS UP
FRIDMAN IMMORTALIZATION DN
NCI TRAIL SIGNALING
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
XU HGF TARGETS INDUCED BY AKT1 48HR UP
TIEN INTESTINE PROBIOTICS 2HR DN
MURATA VIRULENCE OF H PILORI
VART KSHV INFECTION ANGIOGENIC MARKERS UP
REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
SEMENZA HIF1 TARGETS
KYNG ENVIRONMENTAL STRESS RESPONSE UP
NCI AUTODEGRADATION OF CDH1 BY CDH1 APC C
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHAN V1 LATE DIFFERENTIATION GENES UP
NCI NFAT TFPATHWAY
GAUSSMANN MLL AF4 FUSION TARGETS E UP
ONDER CDH1 TARGETS 3 DN
TARTE PLASMA CELL VS B LYMPHOCYTE DN
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN 2FC DN
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
LIAN LIPA TARGETS 6M
DAZARD RESPONSE TO UV NHEK UP
WINTER HYPOXIA METAGENE
NETPATH TNF ALPHA PATHWAY
BROWNE HCMV INFECTION 8HR UP
ISHIKAWA STING SIGNALING
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
LU TUMOR VASCULATURE UP
BOYAULT LIVER CANCER SUBCLASS G2
OSAWA TNF TARGETS
ST G ALPHA S PATHWAY
NCI AMB2 NEUTROPHILS PATHWAY
NOJIMA SFRP2 TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
CLASPER LYMPHATIC VESSELS DURING METASTASIS UP
BROWNE HCMV INFECTION 2HR UP
TAVOR CEBPA TARGETS DN
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE
KIM WT1 TARGETS 12HR UP
ZIRN TRETINOIN RESPONSE UP
SESTO RESPONSE TO UV C3
REACTOME DEATH RECEPTOR SIGNALLING
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
BIOCARTA P38MAPK PATHWAY
GRANDVAUX IRF3 TARGETS UP
SANCHEZ MDM2 TARGETS
ROZANOV MMP14 TARGETS UP
ZHU CMV ALL UP
NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1UBC, PSMA2, PSMA5, UBB, PSMD11, PSMC1, PSMA4, PSMB7, PSMA3, PSMD14, PSMA1, PSMA6, CUL1, PSMD12, PSMD8, PSMC2
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
CREIGHTON AKT1 SIGNALING VIA MTOR DN
REACTOME TCR SIGNALING
KEGG TYPE I DIABETES MELLITUS
AMIT DELAYED EARLY GENES
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NETPATH EGFR1 PATHWAY DOWN
NELSON RESPONSE TO ANDROGEN UP
MARTINELLI IMMATURE NEUTROPHIL DN
RODRIGUES THYROID CARCINOMA DN
LEE LIVER CANCER MYC TGFA UP
BECKER TAMOXIFEN RESISTANCE UP
CHIN BREAST CANCER COPY NUMBER DN
HALMOS CEBPA TARGETS UP
CHIBA RESPONSE TO TSA
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
SAGIV CD24 TARGETS DN
SINGH NFE2L2 TARGETS
WIELAND UP BY HBV INFECTION
COATES MACROPHAGE M1 VS M2 DN
MAHADEVAN RESPONSE TO MP470 DN
WHITESIDE CISPLATIN RESISTANCE DN
RIGGINS TAMOXIFEN RESISTANCE DN
TSAI RESPONSE TO RADIATION THERAPY
NETPATH KIT RECEPTOR PATHWAY UP
HARRIS HYPOXIA
CORUM CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2 COMPLEX
RUGO ENVIRONMENTAL STRESS RESPONSE UP
WU SILENCED BY METHYLATION IN BLADDER CANCER
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
KAN RESPONSE TO ARSENIC TRIOXIDE
NETPATH B CELL RECEPTOR PATHWAY DOWN
SOUCEK MYC TARGETS
BIOCARTA IL5 PATHWAY
BILBAN B CLL LPL DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
TOMLINS METASTASIS DN
GENTILE UV LOW DOSE DN
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
MCCABE HOXC6 TARGETS UP
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK UP
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
ZHAN MULTIPLE MYELOMA SPIKED
REACTOME SIGNALLING TO ERKS
RUTELLA RESPONSE TO HGF DN
WANG ESOPHAGUS CANCER PROGRESSION UP
REACTOME NF KB IS ACTIVATED AND SIGNALS SURVIVAL
BIOCARTA GSK3 PATHWAY
EINAV INTERFERON SIGNATURE IN CANCER
LEE SP4 THYMOCYTE
ST T CELL SIGNAL TRANSDUCTION
AMIT SERUM RESPONSE 40 MCF10A
DE YY1 TARGETS UP
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
BROWNE HCMV INFECTION 4HR UP
ZHU CMV 8 HR UP
HELLER SILENCED BY METHYLATION DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
REACTOME STABILIZATION OF P53
NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC
MAINA VHL TARGETS DN
UDAYAKUMAR MED1 TARGETS DN
SENESE HDAC3 TARGETS UP
LIAN LIPA TARGETS 3M
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP
BUDHU LIVER CANCER METASTASIS UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
XU HGF SIGNALING NOT VIA AKT1 6HR
KOBAYASHI EGFR SIGNALING 6HR DN
MCBRYAN PUBERTAL BREAST 3 4WK DN
JISON SICKLE CELL DISEASE UP
BIOCARTA CTLA4 PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
listeria monocytogenesmycobacterium tuberculosisGeneSet Name
0.00068 0.00008NETPATH_IL_2_PATHWAY_UP
0.00123 0.00534NETPATH_TNF_ALPHA_PATHWAY_UP
0.00163 0.00000GERY_CEBP_TARGETS
0.00000 0.00602NETPATH_IL_1_PATHWAY_UP
0.00100 0.00126NCI_IL23PATHWAY
0.00007 0.00000NETPATH_IL_5_PATHWAY_UP
0.00321 0.01318NCI_LYSOPHOSPHOLIPID_PATHWAY
0.00233 0.00000NETPATH_IL_6_PATHWAY_UP
0.00007 0.00002NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00098 0.01106NETPATH_IL_4_PATHWAY_UP
0.00886 0.01300NCI_IL1PATHWAY
0.00553 0.00171NETPATH_IL_3_PATHWAY_UP
0.03361 0.01252NCI_TNFPATHWAY
0.00001 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.01903 0.00067NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.01410 0.00000MENSE_HYPOXIA_UP
0.01961 0.00144NCI_BCR_5PATHWAY
0.03270 0.01945NETPATH_EGFR1_PATHWAY_UP
0.01903 0.00813NETPATH_WNT_PATHWAY_UP
0.00889 0.00318NCI_HIF1_TFPATHWAY
0.00069 0.00789NCI_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.01375 0.03548GOLUB_ALL_VS_AML_DN
0.01014 0.00572NCI_NFKAPPABCANONICALPATHWAY
0.04905 0.17296TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.17318 0.14894WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.00014 0.00336BIOCARTA_IL10_PATHWAY
0.15654 0.12627REACTOME_SIGNALING_BY_PDGF
0.00965 0.16203NCI_S1P_S1P1_PATHWAY
0.01420 0.02317RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.15925 0.09583CORUM_ITGAV-ITGB5-PLAUR_COMPLEX
0.00046 0.00132MAHAJAN_RESPONSE_TO_IL1A_UP
0.01186 0.03354WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.18363 0.04869MASSARWEH_TAMOXIFEN_RESISTANCE_UP
0.17904 0.04555BROWNE_HCMV_INFECTION_20HR_UP
0.12935 0.19448FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.00437 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00776 0.00118BIOCARTA_IL1R_PATHWAY
0.08880 0.05294ASTON_MAJOR_DEPRESSIVE_DISORDER_DN
0.07380 0.03322BIOCARTA_RELA_PATHWAY
0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.00090 0.07736GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP
0.00001 0.00205SESTO_RESPONSE_TO_UV_C0
0.00411 0.00009GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP
0.00007 0.00000BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.09197 0.00856NETPATH_IL_7_PATHWAY_UP
0.14636 0.00002MUNSHI_MULTIPLE_MYELOMA_UP
0.14707 0.15992AMIT_EGF_RESPONSE_480_HELA
0.04498 0.11340NAKAYAMA_FRA2_TARGETS
0.00110 0.01422NCI_SCF_SKP2__MEDIATED_DEGRADATION_OF_P27_P21
0.06267 0.17506HEDVAT_ELF4_TARGETS_UP
0.00013 0.03860REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.00005 0.00000LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.04948 0.03735KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.06344 0.04080AGARWAL_AKT_PATHWAY_TARGETS
0.19043 0.00000DOUGLAS_BMI1_TARGETS_DN
0.00579 0.00008DORN_ADENOVIRUS_INFECTION_48HR_DN
0.12454 0.02144KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.05112 0.04489SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.19588 0.00247AMIT_EGF_RESPONSE_240_MCF10A
0.02234 0.00001AMIT_SERUM_RESPONSE_60_MCF10A
0.03942 0.02560COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.00178 0.00022GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00346 0.00017HAN_SATB1_TARGETS_DN
0.15032 0.07872BROWNE_HCMV_INFECTION_16HR_UP
0.00178 0.08118NCI_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.02666 0.00018TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.00001 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00000 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.02592 0.00000AMIT_EGF_RESPONSE_120_HELA
0.06178 0.13415VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.01810 0.00299FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00088 0.05314REACTOME_APOPTOSIS
0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.17328 0.04177CHOW_RASSF1_TARGETS_DN
0.01700 0.00756GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.07324 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.03343 0.00047GOZGIT_ESR1_TARGETS_DN
0.00309 0.15875WOOD_EBV_EBNA1_TARGETS_DN
0.12803 0.07952SMID_BREAST_CANCER_LUMINAL_B_DN
0.15021 0.05489SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.00441 0.00000DORN_ADENOVIRUS_INFECTION_24HR_DN
0.00272 0.01697PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.01169 0.04141FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.15374 0.00002AMIT_EGF_RESPONSE_40_MCF10A
0.01514 0.06184REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.04120 0.17649TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.07678 0.04454SPIRA_SMOKERS_LUNG_CANCER_UP
0.00054 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.02242 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.08467 0.16900KEGG_APOPTOSIS
0.03895 0.05414SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
0.00037 0.00348NCI_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX
0.06377 0.00975ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.00002 0.00002CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00001 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.01826 0.00060COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.12016 0.00050BROWNE_HCMV_INFECTION_12HR_UP
0.00001 0.01198SESTO_RESPONSE_TO_UV_C1
0.09757 0.15465BIOCARTA_BCR_PATHWAY
0.15341 0.00171BOYLAN_MULTIPLE_MYELOMA_C_DN
0.04183 0.04602SIMBULAN_UV_RESPONSE_NORMAL_UP
0.03361 0.00065KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.00001 0.00000KIM_LRRC3B_TARGETS
0.05071 0.00850SEMBA_FHIT_TARGETS_UP
0.10505 0.08089DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.07255 0.00000ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.00000 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.07674 0.03776REACTOME_UNFOLDED_PROTEIN_RESPONSE
0.00654 0.00033GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.00166 0.00033GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.00000 0.00000DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.06270 0.04845NETPATH_IL_6_PATHWAY
0.12444 0.00003DIRMEIER_LMP1_RESPONSE_LATE_UP
0.02894 0.00486AMIT_EGF_RESPONSE_20_HELA
0.01226 0.02752HOUSTIS_ROS
0.03739 0.00063BIOCARTA_NTHI_PATHWAY
0.00507 0.00127MARZEC_IL2_SIGNALING_UP
0.08039 0.04300BIOCARTA_BLYMPHOCYTE_PATHWAY
0.04833 0.04027CHIBA_RESPONSE_TO_TSA_DN
0.00904 0.00582ENK_UV_RESPONSE_EPIDERMIS_DN
0.07490 0.11635LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.12871 0.02453BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.01616 0.01999CROMER_TUMORIGENESIS_UP
0.15020 0.00067FRIDMAN_SENESCENCE_UP
0.00791 0.10873WU_HBX_TARGETS_2_DN
0.19957 0.12840SABATES_COLORECTAL_ADENOMA_SIZE_DN
0.17834 0.19850CORUM_UBIQUITIN_E3_LIGASE_TRIM25_DDX58
0.00004 0.00004MAHADEVAN_RESPONSE_TO_MP470_UP
0.06128 0.00018FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.07253 0.01104BIOCARTA_TID_PATHWAY
0.13456 0.14069NETPATH_WNT_PATHWAY_DOWN
0.06249 0.04709NCI_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.09247 0.06717KORKOLA_EMBRYONAL_CARCINOMA
0.12320 0.00738SCHEIDEREIT_IKK_TARGETS
0.00555 0.01686MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.07063 0.03247NCI_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.01005 0.05282SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.16214 0.00420HOEBEKE_LYMPHOID_STEM_CELL_UP
0.06503 0.18546DAZARD_UV_RESPONSE_CLUSTER_G24
0.07302 0.17085MURAKAMI_UV_RESPONSE_6HR_UP
0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.17968 0.01939WANG_METHYLATED_IN_BREAST_CANCER
0.00002 0.01696CORUM_26S_PROTEASOME
0.18537 0.01603HOLLMAN_APOPTOSIS_VIA_CD40_DN
0.00029 0.00505REACTOME_SIGNALING_BY_WNT
0.11822 0.00016RODWELL_AGING_KIDNEY_UP
0.10475 0.00015REACTOME_TOLL_RECEPTOR_CASCADES
0.15285 0.10952BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.00111 0.07867REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC
0.00003 0.07350ONDER_CDH1_TARGETS_1_DN
0.08522 0.08808NCI_SMAD2_3NUCLEARPATHWAY
0.00719 0.00925VALK_AML_CLUSTER_5
0.00266 0.00002MORI_IMMATURE_B_LYMPHOCYTE_UP
0.15303 0.14568REACTOME_ACTIVATED_TLR4_SIGNALLING
0.00142 0.00043ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00001 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00046 0.01224NCI_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A
0.00699 0.00125KIM_WT1_TARGETS_8HR_UP
0.15522 0.00458KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.00887 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.00409 0.04594ELVIDGE_HIF1A_TARGETS_DN
0.16854 0.07997LI_CISPLATIN_RESISTANCE_DN
0.00069 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00001 0.00000ZHU_CMV_24_HR_UP
0.00001 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.03122 0.00165MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.00023 0.11421OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.06346 0.00015CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.07889 0.00691HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.00142 0.03544NETPATH_IL_1_PATHWAY
0.16365 0.01956MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.07527 0.06625XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.00295 0.01230REACTOME_TRANSLOCATION_OF_ZAP70_TO_IMMUNOLOGICAL_SYNAPSE
0.15820 0.05325YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.03989 0.00288NCI_IL6_7PATHWAY
0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.01807 0.00004TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.00228 0.00051REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00096 0.00015ROETH_TERT_TARGETS_UP
0.00030 0.00199TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00695 0.01362KAAB_FAILED_HEART_VENTRICLE_DN
0.00837 0.02412DAZARD_UV_RESPONSE_CLUSTER_G3
0.04416 0.00021OSADA_ASCL1_TARGETS_DN
0.00000 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00016 0.11218BIOCARTA_PROTEASOME_PATHWAY
0.01422 0.00002DUTTA_APOPTOSIS_VIA_NFKB
0.09126 0.13929CORUM_ITGAV-ITGB3-CD47-FCER2_COMPLEX
0.00068 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.00119 0.00707NCI_VPU_MEDIATED_DEGRADATION_OF_CD4
0.09697 0.01539KANG_CISPLATIN_RESISTANCE_UP
0.08760 0.06290BIOCARTA_FREE_PATHWAY
0.00000 0.00002ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00000 0.00000RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.02791 0.09081GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.01127 0.02002NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00070 0.03019NCI_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.07262 0.10893LU_AGING_BRAIN_DN
0.09674 0.00177NEWMAN_ERCC6_TARGETS_UP
0.03155 0.13917NCI_PRLSIGNALINGEVENTSPATHWAY
0.10923 0.19447NCI_CD8TCRPATHWAY
0.00001 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00031 0.01493REACTOME_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE
0.00001 0.00000GAURNIER_PSMD4_TARGETS
0.00001 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00061 0.00000GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.03199 0.00117SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00005 0.01556MARKEY_RB1_CHRONIC_LOF_DN
0.02216 0.00002GESERICK_TERT_TARGETS_DN
0.00040 0.00013AMIT_SERUM_RESPONSE_120_MCF10A
0.00873 0.00006APPEL_IMATINIB_RESPONSE
0.02477 0.00022LEE_LIVER_CANCER_MYC_E2F1_UP
0.01960 0.13774WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.07375 0.06487BASSO_HAIRY_CELL_LEUKEMIA_DN
0.00027 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.11727 0.19472SA_B_CELL_RECEPTOR_COMPLEXES
0.07166 0.00666SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.06748 0.00816REACTOME_SPHINGOLIPID_METABOLISM
0.16339 0.00487CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.00602 0.13562GENTILE_UV_HIGH_DOSE_DN
0.00125 0.00047ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.18525 0.00550REACTOME_VIRAL_DSRNA_TLR3_TRIF_COMPLEX_ACTIVATES_RIP1
0.00031 0.00008GRUETZMANN_PANCREATIC_CANCER_UP
0.00062 0.00809NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION1
0.00777 0.04117OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.00038 0.00367KEGG_PROTEASOME
0.13098 0.00485NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.15378 0.00064KRIGE_AMINO_ACID_DEPRIVATION
0.07129 0.06258GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP
0.01523 0.00004AMIT_EGF_RESPONSE_60_MCF10A
0.01422 0.13983WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.14161 0.08905NCI_NICOTINATE_METABOLISM
0.02915 0.00225KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00069 0.00079CHEN_HOXA5_TARGETS_6HR_UP
0.00015 0.00000SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00328 0.01105LEONARD_HYPOXIA
0.01521 0.00017CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.00417 0.17622NCI_PDGFRAPATHWAY
0.01095 0.00008DORN_ADENOVIRUS_INFECTION_32HR_DN
0.02715 0.00018JIANG_HYPOXIA_NORMAL
0.00267 0.02779WU_CELL_MIGRATION
0.00031 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.06255 0.00956CHANDRAN_METASTASIS_DN
0.10968 0.13295NETPATH_IL_7_PATHWAY_DOWN
0.06270 0.05116SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.16622 0.00500BEIER_GLIOMA_STEM_CELL_DN
0.05613 0.06074BROWNE_HCMV_INFECTION_2HR_DN
0.00298 0.01382GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.05928 0.01736ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.12520 0.19579AMUNDSON_GENOTOXIC_SIGNATURE
0.05283 0.11957EHRLICH_ICF_SYNDROM_DN
0.00201 0.00753DORN_ADENOVIRUS_INFECTION_12HR_DN
0.00008 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00000 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.08045 0.00577CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.04308 0.00022KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.11684 0.10198REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.02146 0.00218REACTOME_INNATE_IMMUNITY_SIGNALING
0.00904 0.00959ENK_UV_RESPONSE_KERATINOCYTE_UP
0.00143 0.02074XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.03417 0.01907GUTIERREZ_MULTIPLE_MYELOMA_DN
0.00000 0.01153LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.07379 0.02725REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.00142 0.00228TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.16870 0.11305CORUM_ITGB3-ITGAV-CD47_COMPLEX
0.17851 0.04209CORUM_ITGA2B-ITGB3-CD47-SRC_COMPLEX
0.04507 0.00478NCI_DOWNSTREAM_TCR_SIGNALING
0.01976 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.05106 0.19958GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
0.02896 0.00130KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.01138 0.10243FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.00016 0.00000DAUER_STAT3_TARGETS_UP
0.00001 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00000 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.03822 0.00342BIOCARTA_RNA_PATHWAY
0.00992 0.18197GRABARCZYK_BCL11B_TARGETS_UP
0.01901 0.03573ZUCCHI_METASTASIS_UP
0.03353 0.08977BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.02795 0.00000AMIT_EGF_RESPONSE_60_HELA
0.03814 0.00008ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.04745 0.01541DAZARD_UV_RESPONSE_CLUSTER_G2
0.00306 0.00008PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.00211 0.03519AMUNDSON_RESPONSE_TO_ARSENITE
0.00000 0.00001MCLACHLAN_DENTAL_CARIES_DN
0.00001 0.00549KEGG_ALLOGRAFT_REJECTION
0.00503 0.00059REACTOME_DOWNSTREAM_TCR_SIGNALING
0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00012 0.05068BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00980 0.04704THUM_SYSTOLIC_HEART_FAILURE_UP
0.04900 0.04359NCI_IL27PATHWAY
0.00023 0.01303SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00310 0.00300TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.17900 0.00367MANALO_HYPOXIA_UP
0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.01434 0.11260KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.12933 0.04041SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.18617 0.00136SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.11592 0.16692NCI_PI3KCIPATHWAY
0.00309 0.00107VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.03984 0.11249NETPATH_ANDROGEN_RECEPTOR_PATHWAY_UP
0.00007 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.15395 0.13973BAELDE_DIABETIC_NEPHROPATHY_DN
0.03297 0.13077NCI_IL12_STAT4PATHWAY
0.00902 0.00022CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.00282 0.12091NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.03349 0.01942HELLER_HDAC_TARGETS_DN
0.00001 0.00002GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.11830 0.10077BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.00056 0.00636NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION
0.01227 0.00022KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.01517 0.02153LU_IL4_SIGNALING
0.00007 0.13943REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.00023 0.00002GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05829 0.14979BIOCARTA_STEM_PATHWAY
0.08391 0.00073BIOCARTA_NFKB_PATHWAY
0.05350 0.06335BIOCARTA_IL6_PATHWAY
0.01117 0.00382VANHARANTA_UTERINE_FIBROID_DN
0.06578 0.00120LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00900 0.02638CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.00003 0.02321KEGG_GRAFT_VERSUS_HOST_DISEASE
0.09100 0.00050KEGG_LYSOSOME
0.00045 0.00787NCI_HOST_INTERACTIONS_OF_HIV_FACTORS
0.02119 0.02642BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.00001 0.00000KRASNOSELSKAYA_ILF3_TARGETS_UP
0.04054 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00043 0.00196LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.19899 0.03217ODONNELL_TFRC_TARGETS_UP
0.00481 0.15708GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.00104 0.02836LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.01417 0.00217IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.14882 0.07491SESTO_RESPONSE_TO_UV_C5
0.00068 0.00000AMIT_EGF_RESPONSE_40_HELA
0.17654 0.11221MILI_PSEUDOPODIA_CHEMOTAXIS_DN
0.10987 0.11206KIM_WT1_TARGETS_12HR_DN
0.00163 0.06597BROWNE_HCMV_INFECTION_10HR_UP
0.10475 0.00845KEGG_SPHINGOLIPID_METABOLISM
0.00418 0.00000MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00028 0.07509REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.00000 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.06536 0.01879MORI_MATURE_B_LYMPHOCYTE_UP
0.00008 0.00000TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.03560 0.09937CONRAD_GERMLINE_STEM_CELL
0.08063 0.05130MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.00001 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.04075 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.00011 0.08660CORUM_PA28GAMMA-20S_PROTEASOME
0.00004 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00307 0.00912REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.00065 0.00000XU_AKT1_TARGETS_6HR
0.17574 0.00340COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN
0.08448 0.02064DORSEY_GAB2_TARGETS
0.02652 0.07524TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.01413 0.01142POOLA_INVASIVE_BREAST_CANCER_UP
0.00003 0.00477RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.01016 0.00067LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.01108 0.09738SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.00045 0.00051BROWNE_HCMV_INFECTION_6HR_UP
0.00000 0.00000DAUER_STAT3_TARGETS_DN
0.17317 0.03099BIOCARTA_RANKL_PATHWAY
0.01850 0.00880DANG_REGULATED_BY_MYC_DN
0.05596 0.06480NCI_TGFBRPATHWAY
0.02770 0.01756BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN
0.01078 0.00911SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00004 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.01376 0.04601WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN
0.17958 0.05412DIRMEIER_LMP1_RESPONSE_LATE_DN
0.00003 0.00095HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.04089 0.00097JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.17672 0.16855CORUM_ABIN2-NFKB1-MAP3K8_COMPLEX
0.04501 0.00460KYNG_DNA_DAMAGE_UP
0.02021 0.00014LEE_LIVER_CANCER_E2F1_UP
0.15281 0.19650NCI_REDUCTION_OF_CYTOSOLIC_RIBONUCLEOSIDE_5__DIPHOSPHATES_TO_DEOXYRIBONUCLEOSIDE_5__DIPHOSPHATES_BY_RIBONUCLEOTIDE_REDUCTASE_AND_THIOREDOXIN
0.04978 0.02317WANG_SMARCE1_TARGETS_DN
0.00001 0.00000BOWIE_RESPONSE_TO_TAMOXIFEN
0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.01807 0.14576TOOKER_GEMCITABINE_RESISTANCE_DN
0.00011 0.00021ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.19028 0.02660SUNG_METASTASIS_STROMA_UP
0.05923 0.03994NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.02665 0.02450NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.02711 0.02147VANTVEER_BREAST_CANCER_ESR1_DN
0.16995 0.00007FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.11173 0.15494STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.00011 0.01568CORUM_PA700-20S-PA28_COMPLEX
0.07809 0.10884REACTOME_TOLL_LIKE_RECEPTOR_4_CASCADE
0.00001 0.00000BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.05382 0.00526GENTILE_UV_RESPONSE_CLUSTER_D6
0.14599 0.08955NCI_P53DOWNSTREAMPATHWAY
0.04187 0.00051NCI_IL12_2PATHWAY
0.00212 0.00015TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.17259 0.00035HUMMEL_BURKITTS_LYMPHOMA_DN
0.00488 0.17564GENTILE_UV_LOW_DOSE_UP
0.02089 0.00619HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.11840 0.00023LEE_EARLY_T_LYMPHOCYTE_DN
0.07424 0.00030HUANG_DASATINIB_RESISTANCE_UP
0.00031 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.03977 0.00827NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
0.02746 0.05131FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
0.11566 0.07394KOYAMA_SEMA3B_TARGETS_DN
0.00010 0.00000PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP
0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.00167 0.00000CHANG_IMMORTALIZED_BY_HPV31_DN
0.16280 0.16542NCI_ERBB1_DOWNSTREAM_PATHWAY
0.11147 0.17729WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
0.05925 0.00025CROONQUIST_STROMAL_STIMULATION_UP
0.04438 0.00814SA_MMP_CYTOKINE_CONNECTION
0.07538 0.06332DORN_ADENOVIRUS_INFECTION_48HR_UP
0.17841 0.00019ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.03125 0.00143BLUM_RESPONSE_TO_SALIRASIB_UP
0.15145 0.02574KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.03312 0.07656LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.00482 0.17875NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_SECURIN
0.10702 0.00000KHETCHOUMIAN_TRIM24_TARGETS_UP
0.01805 0.00000HORIUCHI_WTAP_TARGETS_UP
0.05743 0.01264ONKEN_UVEAL_MELANOMA_UP
0.00254 0.01169CORUM_PA28-20S_PROTEASOME
0.02117 0.00008DORN_ADENOVIRUS_INFECTION_12HR_UP
0.09180 0.01412DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.07394 0.16621DORN_ADENOVIRUS_INFECTION_32HR_UP
0.15353 0.02415RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.02563 0.13686BIOCARTA_TH1TH2_PATHWAY
0.01474 0.00004TSAI_DNAJB4_TARGETS_UP
0.00000 0.00000DER_IFN_BETA_RESPONSE_UP
0.00150 0.00014MORI_PRE_BI_LYMPHOCYTE_DN
0.17033 0.17760NCI_REGULATED_PROTEOLYSIS_OF_P75NTR
0.14957 0.06095GILDEA_METASTASIS
0.00061 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.00020 0.00000BASSO_CD40_SIGNALING_UP
0.01298 0.00011TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.11763 0.04578BIOCARTA_FCER1_PATHWAY
0.05673 0.18427IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
0.00045 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.05033 0.04554ZERBINI_RESPONSE_TO_SULINDAC_UP
0.11852 0.15012CORUM_UBIQUITIN_E3_LIGASE_NFKBIA_BTRC_CUL1_SKP1A
0.17037 0.00019WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.11563 0.15032CORUM_SDCBP-CTNNB1-CTNNA1-CDH1_COMPLEX
0.03363 0.00218NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.04182 0.04684SASSON_RESPONSE_TO_FORSKOLIN_DN
0.05669 0.00002KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.05104 0.00534ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.01751 0.19590KEGG_VIRAL_MYOCARDITIS
0.00069 0.00468REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.00055 0.00007KEGG_LEISHMANIA_INFECTION
0.00162 0.01228REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.00371 0.04633ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.03609 0.10092SMITH_TERT_TARGETS_UP
0.00000 0.00006CHEN_HOXA5_TARGETS_9HR_UP
0.03753 0.00619WANG_RECURRENT_LIVER_CANCER_DN
0.00899 0.14786RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.12229 0.02502BIOCARTA_DEATH_PATHWAY
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.07826 0.08799ALCALAY_AML_BY_NPM1_LOCALIZATION_UP
0.00000 0.00000REACTOME_DNA_STRAND_ELONGATION
0.00097 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00060 0.00028CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00001BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00081 0.00551NCI_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1
0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.14781 0.09262RICKMAN_HEAD_AND_NECK_CANCER_C
0.00842 0.00830SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN
0.00550 0.10630BIOCARTA_ASBCELL_PATHWAY
0.00025 0.05869CORUM_20S_PROTEASOME
0.00009 0.04425SENESE_HDAC1_TARGETS_UP
0.07256 0.00244WANG_CLIM2_TARGETS_DN
0.01564 0.00007KIM_WT1_TARGETS_UP
0.02184 0.00334REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.00588 0.00059KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.07385 0.04134STREICHER_LSM1_TARGETS_UP
0.08123 0.00175CROONQUIST_NRAS_SIGNALING_UP
0.00001 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.15772 0.03902CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN
0.00423 0.03451AMIT_EGF_RESPONSE_120_MCF10A
0.06135 0.00265MAHADEVAN_IMATINIB_RESISTANCE_UP
0.06391 0.14310BIOCARTA_HIF_PATHWAY
0.00007 0.00000RUTELLA_RESPONSE_TO_HGF_UP
0.01784 0.13174TOOKER_RESPONSE_TO_BEXAROTENE_UP
0.01526 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.06387 0.03057YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.05106 0.15152LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.00405 0.00266REACTOME_PD1_SIGNALING
0.16398 0.10035CORUM_ITGAV-ITGB5-ADAM9_COMPLEX
0.05769 0.02988NETPATH_IL_5_PATHWAY
0.00624 0.02320BIOCARTA_PML_PATHWAY
0.16194 0.00016LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.07094 0.19122NCI_GAB1_SIGNALOSOME
0.00456 0.00098HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.00070 0.00000BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.03943 0.06690SWEET_LUNG_CANCER_KRAS_UP
0.09679 0.13556TENEDINI_MEGAKARYOCYTE_MARKERS
0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.19970 0.02883BASAKI_YBX1_TARGETS_DN
0.09034 0.07785HOFMANN_CELL_LYMPHOMA_DN
0.00023 0.00052ELVIDGE_HYPOXIA_UP
0.13552 0.10897PROVENZANI_METASTASIS_DN
0.05110 0.15995YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8
0.12460 0.03785WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.00026 0.00749SESTO_RESPONSE_TO_UV_C2
0.01129 0.04549TIEN_INTESTINE_PROBIOTICS_24HR_DN
0.00090 0.00000NUYTTEN_NIPP1_TARGETS_UP
0.16402 0.00089FRIDMAN_IMMORTALIZATION_DN
0.09568 0.02528NCI_TRAIL__SIGNALING
0.00736 0.00060KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.04325 0.00027XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.00900 0.15097TIEN_INTESTINE_PROBIOTICS_2HR_DN
0.02078 0.05724MURATA_VIRULENCE_OF_H_PILORI
0.01472 0.01566VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00054 0.00470REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.13958 0.00008TSAI_RESPONSE_TO_IONIZING_RADIATION
0.05915 0.00018DELYS_THYROID_CANCER_UP
0.00199 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00181 0.00469KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00011 0.04672SEMENZA_HIF1_TARGETS
0.16495 0.00275KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.00143 0.08317NCI_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.02300 0.04074ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.05773 0.00205NCI_NFAT_TFPATHWAY
0.09652 0.11855GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.00011 0.10086ONDER_CDH1_TARGETS_3_DN
0.09768 0.02077TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.17670 0.03321SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.00001 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.16188 0.00036HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.00075 0.00002LIAN_LIPA_TARGETS_6M
0.01225 0.00196DAZARD_RESPONSE_TO_UV_NHEK_UP
0.00186 0.00019WINTER_HYPOXIA_METAGENE
0.08032 0.07034NETPATH_TNF_ALPHA_PATHWAY
0.00128 0.00000BROWNE_HCMV_INFECTION_8HR_UP
0.02022 0.00865ISHIKAWA_STING_SIGNALING
0.00001 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00125 0.00011TAVOR_CEBPA_TARGETS_UP
0.01828 0.00083LU_TUMOR_VASCULATURE_UP
0.16425 0.12852BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.05254 0.07502OSAWA_TNF_TARGETS
0.12938 0.06631ST_G_ALPHA_S_PATHWAY
0.18259 0.09678NCI_AMB2_NEUTROPHILS_PATHWAY
0.02237 0.00051NOJIMA_SFRP2_TARGETS_DN
0.14664 0.03737KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.15408 0.05159CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.02059 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.01645 0.00294TAVOR_CEBPA_TARGETS_DN
0.00069 0.02161REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE
0.16372 0.00863KIM_WT1_TARGETS_12HR_UP
0.14854 0.03003ZIRN_TRETINOIN_RESPONSE_UP
0.00002 0.00000SESTO_RESPONSE_TO_UV_C3
0.07287 0.01374REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00032 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.16637 0.06871BIOCARTA_P38MAPK_PATHWAY
0.01357 0.00065GRANDVAUX_IRF3_TARGETS_UP
0.00227 0.00549SANCHEZ_MDM2_TARGETS
0.05511 0.00007ROZANOV_MMP14_TARGETS_UP
0.00000 0.00000ZHU_CMV_ALL_UP
0.00045 0.00570NCI_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.02848 0.13990LEE_LIVER_CANCER_HEPATOBLAST
0.00001 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.11982 0.05494CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN
0.00795 0.00496REACTOME_TCR_SIGNALING
0.00007 0.06667KEGG_TYPE_I_DIABETES_MELLITUS
0.00200 0.00001AMIT_DELAYED_EARLY_GENES
0.00045 0.00003RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.02668 0.00000NOJIMA_SFRP2_TARGETS_UP
0.00001 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.05099 0.00000NETPATH_EGFR1_PATHWAY_DOWN
0.02410 0.19447NELSON_RESPONSE_TO_ANDROGEN_UP
0.03651 0.11442MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.00235 0.01698RODRIGUES_THYROID_CARCINOMA_DN
0.00938 0.00029LEE_LIVER_CANCER_MYC_TGFA_UP
0.00235 0.00573BECKER_TAMOXIFEN_RESISTANCE_UP
0.13475 0.19580CHIN_BREAST_CANCER_COPY_NUMBER_DN
0.01542 0.01212HALMOS_CEBPA_TARGETS_UP
0.07393 0.00009CHIBA_RESPONSE_TO_TSA
0.02485 0.00294YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.00001 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.09742 0.00000SAGIV_CD24_TARGETS_DN
0.00052 0.00074SINGH_NFE2L2_TARGETS
0.00000 0.00000WIELAND_UP_BY_HBV_INFECTION
0.14232 0.02011COATES_MACROPHAGE_M1_VS_M2_DN
0.01146 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.06425 0.08609WHITESIDE_CISPLATIN_RESISTANCE_DN
0.03786 0.00771RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.05481 0.00000TSAI_RESPONSE_TO_RADIATION_THERAPY
0.05671 0.00019NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.00067HARRIS_HYPOXIA
0.05617 0.00431CORUM_CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2_COMPLEX
0.10205 0.00227RUGO_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.01520 0.12876WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.00001 0.00089DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00399 0.00571KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00901 0.19466NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.09270 0.02521SOUCEK_MYC_TARGETS
0.01405 0.05187BIOCARTA_IL5_PATHWAY
0.01132 0.01866BILBAN_B_CLL_LPL_DN
0.12277 0.00317KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00386 0.00047IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.13417 0.06616TOMLINS_METASTASIS_DN
0.00587 0.19320GENTILE_UV_LOW_DOSE_DN
0.00177 0.00000ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00296 0.00343KEGG_AUTOIMMUNE_THYROID_DISEASE
0.05738 0.00137TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.12447 0.13559MCCABE_HOXC6_TARGETS_UP
0.00228 0.00012FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.00105 0.00240SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.14239 0.00289ZHAN_MULTIPLE_MYELOMA_SPIKED
0.11680 0.11704REACTOME_SIGNALLING_TO_ERKS
0.05674 0.00287RUTELLA_RESPONSE_TO_HGF_DN
0.19686 0.00139WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.06528 0.02942REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.18838 0.02075BIOCARTA_GSK3_PATHWAY
0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.06132 0.00049LEE_SP4_THYMOCYTE
0.05774 0.02873ST_T_CELL_SIGNAL_TRANSDUCTION
0.00799 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.18965 0.15010DE_YY1_TARGETS_UP
0.06392 0.00601HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00001 0.00024BROWNE_HCMV_INFECTION_4HR_UP
0.00000 0.00000ZHU_CMV_8_HR_UP
0.07386 0.00045HELLER_SILENCED_BY_METHYLATION_DN
0.00004 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00306 0.00036SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00954 0.00001XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00554 0.00500ONDER_CDH1_TARGETS_2_DN
0.00163 0.00975REACTOME_STABILIZATION_OF_P53
0.00061 0.02665NCI_REGULATION_OF_ORNITHINE_DECARBOXYLASE__ODC_
0.11399 0.00177MAINA_VHL_TARGETS_DN
0.09209 0.00070UDAYAKUMAR_MED1_TARGETS_DN
0.00256 0.00552SENESE_HDAC3_TARGETS_UP
0.00018 0.00000LIAN_LIPA_TARGETS_3M
0.17966 0.02836KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
0.01011 0.05729BUDHU_LIVER_CANCER_METASTASIS_UP
0.00737 0.01103CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00146 0.00239XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.01417 0.00020KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.04307 0.01383MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.00000 0.00000JISON_SICKLE_CELL_DISEASE_UP
0.13448 0.02940BIOCARTA_CTLA4_PATHWAY
0.00850 0.00469XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00595 0.00006DASU_IL6_SIGNALING_UP
0.00518 0.00039ZUCCHI_METASTASIS_DN
0.00484 0.06983BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.00107 0.00812DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN